MHAPT Zarita Johanna University Hospital Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2006
NCT00857480
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

MHAPT Zaritza Johanna University Hospital

Active Ingredients

Drugs in Phase 1 Trials (1)

fluorescein (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Liver Cirrhosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1